- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
DANGEROUS DRUGS
Made
5th June 2003
Laid before Parliament
5th June 2003
Coming into force
1st July 2003
In pursuance of sections 10 and 31 of the Misuse of Drugs Act 1971(1), after consultation with the Advisory Council on the Misuse of Drugs, the Secretary of State hereby makes the following Regulations:
1. These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2003 and shall come into force on 1st July 2003.
2.—(1) The Misuse of Drugs Regulations 2001(2), shall be amended as follows.
(2) In paragraph 1 of Schedule 2 there shall be inserted—
(a)after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and
(b)after “Racemorphan”, “Remifentanil”.
(3) In paragraph 1, Part 1 of Schedule 4 there shall be inserted—
(a)after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and
(b)after “N-Ethylamphetamine”, “Zolpidem”.
(4) In paragraph 1, Part II of Schedule 4 there shall be inserted—
(a)before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17 diol”; and
(b)after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione” and “19-Nor-5-Androstene-3, 17 diol”.
Bob Ainsworth
Parliamentary Under-Secretary of State
Home Office
5th June 2003
(This note is not part of the Regulations)
These Regulations amend the Misuse of Drugs Regulations 2001 by adding two substances to paragraph 1 of Schedule 2 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) two substances to Part I of Schedule 4 (controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) and four substances to Part II of Schedule 4 (controlled drugs excepted from the prohibition on possession when in the form of a medicinal product; excluded from the application of offences arising from the prohibition on importation and exportation when imported or exported in the form of a medicinal product by any person for administration to himself; and subject to the requirements of regulations 22, 23, 26 and 27).
S.I. 2001/3998.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: